RecallDepth
Class I Terminated

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

This recall has been terminated (originally issued October 9, 2024).

Company
Gilead Sciences, Inc.
Recall Initiated
September 19, 2024
Posted
October 9, 2024
Recall Number
D-0005-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
105,000 vials
Firm Location
Foster City, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Particulate Matter: Presence of glass particle.

Distribution

Nationwide in the U.S.A.

Lot / Code Info

Lot: 47035CFA, Exp. 11/2025

More recalls by Gilead Sciences, Inc.

View all recalls by this company →

Other recent Class I Drug recalls